APA (7th ed.) Citation

IM, M., M, M., R, S., F, M., L, G., Q, W., . . . JA, R. (2025). NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model. ELife, 13, . https://doi.org/10.7554/eLife.98258

Chicago Style (17th ed.) Citation

IM, Meraz, Majidi M, Song R, Meng F, Gao L, Wang Q, Wang J, Shpall EJ, and Roth JA. "NPRL2 Gene Therapy Induces Effective Antitumor Immunity in KRAS/STK11 Mutant Anti-PD1 Resistant Metastatic Non-small Cell Lung Cancer (NSCLC) in a Humanized Mouse Model." ELife 13 (2025). https://doi.org/10.7554/eLife.98258.

MLA (9th ed.) Citation

IM, Meraz, et al. "NPRL2 Gene Therapy Induces Effective Antitumor Immunity in KRAS/STK11 Mutant Anti-PD1 Resistant Metastatic Non-small Cell Lung Cancer (NSCLC) in a Humanized Mouse Model." ELife, vol. 13, 2025, https://doi.org/10.7554/eLife.98258.